focus -WSS

focus

author：Wikipedia 2025-09-05 13:33:11 - browse：9

Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： After gene therapy, two congenitally deaf children hear for the first time

WSS

Researchers on aging grapple with how to calculate biological age

Drug companies' payments and gifts affect physicians' prescribing

Bird flu reported in person exposed to presumably infected cattle

Drug companies' payments and gifts affect physicians' prescribing

People with mental disorders often marry others with same

U.K. decision on ALS drug has neurologists, advocates up in arms

Wikipedia

focus

focus

In age of alternative facts, a scholarly course on calling out crap

H5N1 communication has been strictly for the birds

Sports medicine is finally prioritizing gender equality

Overprescribed: High cost isn't America's only drug problem

After affirmative action ruling, medical educators look to 'holistic review'

Telehealth startups turn to complex chronic diseases

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alzheimer's risk factor APOE4 may be a distinct form of the disease

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Scientific mystery highlights the blind spots in genomics databases

leisure time

Drug companies' payments and gifts affect physicians' prescribing

Hundreds died while taking an arthritis drug, but nobody alerted patients

CDC wastewater surveillance dashboard to track bird flu hotspots

Elevance, private equity launch primary care company

Bird flu outbreak in cows is latest avian flu curveball

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

entertainment

entertainment

Wikipedia

hotspot